nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CCR5—hypertension	0.483	1	CbGaD
Maraviroc—CYP3A4—Guanethidine—hypertension	0.0242	0.11	CbGbCtD
Maraviroc—CYP3A4—Hydralazine—hypertension	0.0183	0.0837	CbGbCtD
Maraviroc—CYP3A4—Guanfacine—hypertension	0.0156	0.0712	CbGbCtD
Maraviroc—CYP3A4—Isradipine—hypertension	0.0139	0.0634	CbGbCtD
Maraviroc—CYP3A4—Nisoldipine—hypertension	0.0122	0.0558	CbGbCtD
Maraviroc—CYP3A4—Indapamide—hypertension	0.0122	0.0558	CbGbCtD
Maraviroc—CYP3A4—Eplerenone—hypertension	0.0118	0.0539	CbGbCtD
Maraviroc—CYP3A4—Diltiazem—hypertension	0.0118	0.0539	CbGbCtD
Maraviroc—CYP3A4—Enalapril—hypertension	0.0105	0.0481	CbGbCtD
Maraviroc—CYP3A4—Irbesartan—hypertension	0.00962	0.044	CbGbCtD
Maraviroc—CYP3A4—Amlodipine—hypertension	0.00944	0.0431	CbGbCtD
Maraviroc—CYP3A4—Felodipine—hypertension	0.0091	0.0416	CbGbCtD
Maraviroc—CYP3A4—Nifedipine—hypertension	0.0088	0.0402	CbGbCtD
Maraviroc—CYP3A4—Nicardipine—hypertension	0.00866	0.0396	CbGbCtD
Maraviroc—CYP3A4—Carvedilol—hypertension	0.00866	0.0396	CbGbCtD
Maraviroc—CYP3A4—Propranolol—hypertension	0.00797	0.0364	CbGbCtD
Maraviroc—CYP3A4—Clonidine—hypertension	0.00761	0.0348	CbGbCtD
Maraviroc—CYP3A4—Atorvastatin—hypertension	0.00678	0.031	CbGbCtD
Maraviroc—CYP3A4—Losartan—hypertension	0.0062	0.0283	CbGbCtD
Maraviroc—CYP3A4—Verapamil—hypertension	0.00547	0.025	CbGbCtD
Maraviroc—CCR5—heart—hypertension	0.00186	0.264	CbGeAlD
Maraviroc—CCR5—cardiovascular system—hypertension	0.00175	0.249	CbGeAlD
Maraviroc—CCR5—endocrine gland—hypertension	0.0012	0.171	CbGeAlD
Maraviroc—CCR5—central nervous system—hypertension	0.00108	0.154	CbGeAlD
Maraviroc—CYP3A4—urine—hypertension	0.000731	0.104	CbGeAlD
Maraviroc—CYP3A4—kidney—hypertension	0.000173	0.0246	CbGeAlD
Maraviroc—CYP3A4—endocrine gland—hypertension	0.000121	0.0172	CbGeAlD
Maraviroc—CYP3A4—central nervous system—hypertension	0.000109	0.0155	CbGeAlD
Maraviroc—CCR5—Disease—CALM1—hypertension	2.61e-05	0.000244	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HDAC1—hypertension	2.6e-05	0.000243	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—STK11—hypertension	2.6e-05	0.000243	CbGpPWpGaD
Maraviroc—CCR5—Disease—APOE—hypertension	2.6e-05	0.000243	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL2—hypertension	2.59e-05	0.000242	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL10—hypertension	2.58e-05	0.000241	CbGpPWpGaD
Maraviroc—CCR5—Disease—CAV1—hypertension	2.57e-05	0.000241	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PLG—hypertension	2.57e-05	0.000241	CbGpPWpGaD
Maraviroc—CCR5—Disease—APOA1—hypertension	2.57e-05	0.00024	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—RHOA—hypertension	2.57e-05	0.00024	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—hypertension	2.55e-05	0.000239	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—AKT2—hypertension	2.54e-05	0.000238	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PIK3R1—hypertension	2.54e-05	0.000238	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—hypertension	2.54e-05	0.000238	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—TBXAS1—hypertension	2.51e-05	0.000235	CbGpPWpGaD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—hypertension	2.5e-05	0.000234	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ADRB2—hypertension	2.5e-05	0.000234	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PRKCE—hypertension	2.47e-05	0.000231	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PDGFA—hypertension	2.44e-05	0.000229	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—VAV3—hypertension	2.44e-05	0.000229	CbGpPWpGaD
Maraviroc—CCR5—Disease—NOS2—hypertension	2.42e-05	0.000227	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TGFBR2—hypertension	2.41e-05	0.000225	CbGpPWpGaD
Maraviroc—CCR5—Disease—NOTCH1—hypertension	2.4e-05	0.000224	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GNB3—hypertension	2.38e-05	0.000223	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AVP—hypertension	2.35e-05	0.00022	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—RHOA—hypertension	2.33e-05	0.000218	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GNAS—hypertension	2.32e-05	0.000217	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PIK3R1—hypertension	2.31e-05	0.000216	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—APOB—hypertension	2.27e-05	0.000213	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PTK2—hypertension	2.26e-05	0.000212	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCL8—hypertension	2.25e-05	0.000211	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP2C18—hypertension	2.24e-05	0.000209	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—EDN1—hypertension	2.24e-05	0.000209	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL5—hypertension	2.22e-05	0.000208	CbGpPWpGaD
Maraviroc—CCR5—Disease—INS—hypertension	2.22e-05	0.000208	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP2C18—hypertension	2.21e-05	0.000207	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LPL—hypertension	2.17e-05	0.000203	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—H2AFX—hypertension	2.16e-05	0.000202	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RPS6KB1—hypertension	2.15e-05	0.000201	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PDGFRB—hypertension	2.15e-05	0.000201	CbGpPWpGaD
Maraviroc—CCR5—Disease—AKT2—hypertension	2.15e-05	0.000201	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ADCY5—hypertension	2.13e-05	0.000199	CbGpPWpGaD
Maraviroc—Fatigue—Losartan—hypertension	2.12e-05	0.000115	CcSEcCtD
Maraviroc—Dermatitis—Doxazosin—hypertension	2.12e-05	0.000115	CcSEcCtD
Maraviroc—Gastrointestinal pain—Hydrochlorothiazide—hypertension	2.12e-05	0.000115	CcSEcCtD
Maraviroc—Vomiting—Fosinopril—hypertension	2.12e-05	0.000115	CcSEcCtD
Maraviroc—Nausea—Propranolol—hypertension	2.11e-05	0.000115	CcSEcCtD
Maraviroc—Oedema—Ramipril—hypertension	2.11e-05	0.000115	CcSEcCtD
Maraviroc—Headache—Doxazosin—hypertension	2.11e-05	0.000115	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PRKCG—hypertension	2.11e-05	0.000198	CbGpPWpGaD
Maraviroc—Constipation—Losartan—hypertension	2.11e-05	0.000114	CcSEcCtD
Maraviroc—Pain—Losartan—hypertension	2.11e-05	0.000114	CcSEcCtD
Maraviroc—Syncope—Lisinopril—hypertension	2.1e-05	0.000114	CcSEcCtD
Maraviroc—Vomiting—Eplerenone—hypertension	2.1e-05	0.000114	CcSEcCtD
Maraviroc—Leukopenia—Lisinopril—hypertension	2.1e-05	0.000114	CcSEcCtD
Maraviroc—Rash—Fosinopril—hypertension	2.1e-05	0.000114	CcSEcCtD
Maraviroc—Dermatitis—Fosinopril—hypertension	2.1e-05	0.000114	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ITGB3—hypertension	2.1e-05	0.000196	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PRKCA—hypertension	2.1e-05	0.000196	CbGpPWpGaD
Maraviroc—Vomiting—Nifedipine—hypertension	2.09e-05	0.000113	CcSEcCtD
Maraviroc—Gastrointestinal pain—Furosemide—hypertension	2.09e-05	0.000113	CcSEcCtD
Maraviroc—Rash—Eplerenone—hypertension	2.09e-05	0.000113	CcSEcCtD
Maraviroc—Headache—Fosinopril—hypertension	2.09e-05	0.000113	CcSEcCtD
Maraviroc—Hypersensitivity—Trandolapril—hypertension	2.09e-05	0.000113	CcSEcCtD
Maraviroc—Dermatitis—Eplerenone—hypertension	2.09e-05	0.000113	CcSEcCtD
Maraviroc—Diarrhoea—Valsartan—hypertension	2.08e-05	0.000113	CcSEcCtD
Maraviroc—Asthenia—Clonidine—hypertension	2.08e-05	0.000113	CcSEcCtD
Maraviroc—Vomiting—Verapamil—hypertension	2.08e-05	0.000113	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—YWHAZ—hypertension	2.08e-05	0.000195	CbGpPWpGaD
Maraviroc—Shock—Ramipril—hypertension	2.08e-05	0.000113	CcSEcCtD
Maraviroc—Hypersensitivity—Enalapril—hypertension	2.08e-05	0.000113	CcSEcCtD
Maraviroc—Body temperature increased—Perindopril—hypertension	2.08e-05	0.000113	CcSEcCtD
Maraviroc—Abdominal pain—Perindopril—hypertension	2.08e-05	0.000113	CcSEcCtD
Maraviroc—Diarrhoea—Olmesartan—hypertension	2.07e-05	0.000113	CcSEcCtD
Maraviroc—Headache—Eplerenone—hypertension	2.07e-05	0.000113	CcSEcCtD
Maraviroc—Rash—Nifedipine—hypertension	2.07e-05	0.000113	CcSEcCtD
Maraviroc—Nervous system disorder—Ramipril—hypertension	2.07e-05	0.000113	CcSEcCtD
Maraviroc—Dermatitis—Nifedipine—hypertension	2.07e-05	0.000112	CcSEcCtD
Maraviroc—Abdominal pain—Irbesartan—hypertension	2.07e-05	0.000112	CcSEcCtD
Maraviroc—Body temperature increased—Irbesartan—hypertension	2.07e-05	0.000112	CcSEcCtD
Maraviroc—Oedema—Timolol—hypertension	2.06e-05	0.000112	CcSEcCtD
Maraviroc—Loss of consciousness—Lisinopril—hypertension	2.06e-05	0.000112	CcSEcCtD
Maraviroc—Rash—Verapamil—hypertension	2.06e-05	0.000112	CcSEcCtD
Maraviroc—Dermatitis—Verapamil—hypertension	2.06e-05	0.000112	CcSEcCtD
Maraviroc—Headache—Nifedipine—hypertension	2.06e-05	0.000112	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—hypertension	2.06e-05	0.000193	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NGF—hypertension	2.06e-05	0.000192	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SPP1—hypertension	2.06e-05	0.000192	CbGpPWpGaD
Maraviroc—Pruritus—Clonidine—hypertension	2.05e-05	0.000112	CcSEcCtD
Maraviroc—Abdominal pain—Hydrochlorothiazide—hypertension	2.05e-05	0.000111	CcSEcCtD
Maraviroc—Body temperature increased—Hydrochlorothiazide—hypertension	2.05e-05	0.000111	CcSEcCtD
Maraviroc—Skin disorder—Ramipril—hypertension	2.05e-05	0.000111	CcSEcCtD
Maraviroc—Infection—Timolol—hypertension	2.05e-05	0.000111	CcSEcCtD
Maraviroc—Headache—Verapamil—hypertension	2.05e-05	0.000111	CcSEcCtD
Maraviroc—Hypersensitivity—Telmisartan—hypertension	2.05e-05	0.000111	CcSEcCtD
Maraviroc—Cough—Lisinopril—hypertension	2.05e-05	0.000111	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CXCL8—hypertension	2.05e-05	0.000192	CbGpPWpGaD
Maraviroc—Nausea—Indapamide—hypertension	2.04e-05	0.000111	CcSEcCtD
Maraviroc—Nausea—Diltiazem—hypertension	2.04e-05	0.000111	CcSEcCtD
Maraviroc—CCR5—Disease—SERPINE1—hypertension	2.04e-05	0.000191	CbGpPWpGaD
Maraviroc—Asthenia—Trandolapril—hypertension	2.03e-05	0.00011	CcSEcCtD
Maraviroc—Shock—Timolol—hypertension	2.03e-05	0.00011	CcSEcCtD
Maraviroc—Nervous system disorder—Timolol—hypertension	2.02e-05	0.00011	CcSEcCtD
Maraviroc—Nausea—Carvedilol—hypertension	2.02e-05	0.00011	CcSEcCtD
Maraviroc—Asthenia—Enalapril—hypertension	2.02e-05	0.00011	CcSEcCtD
Maraviroc—Abdominal pain—Furosemide—hypertension	2.02e-05	0.00011	CcSEcCtD
Maraviroc—Body temperature increased—Furosemide—hypertension	2.02e-05	0.00011	CcSEcCtD
Maraviroc—Gastrointestinal pain—Losartan—hypertension	2.01e-05	0.000109	CcSEcCtD
Maraviroc—Dizziness—Valsartan—hypertension	2.01e-05	0.000109	CcSEcCtD
Maraviroc—Anorexia—Ramipril—hypertension	2.01e-05	0.000109	CcSEcCtD
Maraviroc—Skin disorder—Timolol—hypertension	2.01e-05	0.000109	CcSEcCtD
Maraviroc—Dizziness—Olmesartan—hypertension	2e-05	0.000109	CcSEcCtD
Maraviroc—Pruritus—Trandolapril—hypertension	2e-05	0.000109	CcSEcCtD
Maraviroc—Nausea—Doxazosin—hypertension	2e-05	0.000109	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PRKCD—hypertension	2e-05	0.000187	CbGpPWpGaD
Maraviroc—Myalgia—Lisinopril—hypertension	2e-05	0.000109	CcSEcCtD
Maraviroc—Body temperature increased—Betaxolol—hypertension	2e-05	0.000109	CcSEcCtD
Maraviroc—Asthenia—Telmisartan—hypertension	2e-05	0.000108	CcSEcCtD
Maraviroc—Pruritus—Enalapril—hypertension	2e-05	0.000108	CcSEcCtD
Maraviroc—Anxiety—Lisinopril—hypertension	1.99e-05	0.000108	CcSEcCtD
Maraviroc—Diarrhoea—Clonidine—hypertension	1.99e-05	0.000108	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	1.98e-05	0.000108	CcSEcCtD
Maraviroc—Nausea—Fosinopril—hypertension	1.98e-05	0.000107	CcSEcCtD
Maraviroc—Discomfort—Lisinopril—hypertension	1.97e-05	0.000107	CcSEcCtD
Maraviroc—CCR5—Disease—FGF2—hypertension	1.97e-05	0.000185	CbGpPWpGaD
Maraviroc—Anorexia—Timolol—hypertension	1.97e-05	0.000107	CcSEcCtD
Maraviroc—Pruritus—Telmisartan—hypertension	1.97e-05	0.000107	CcSEcCtD
Maraviroc—CCR5—Disease—RHOA—hypertension	1.97e-05	0.000184	CbGpPWpGaD
Maraviroc—Nausea—Eplerenone—hypertension	1.97e-05	0.000107	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—GPX3—hypertension	1.96e-05	0.000183	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR2A—hypertension	1.96e-05	0.000183	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—C3—hypertension	1.95e-05	0.000183	CbGpPWpGaD
Maraviroc—Nausea—Nifedipine—hypertension	1.95e-05	0.000106	CcSEcCtD
Maraviroc—Abdominal pain—Losartan—hypertension	1.95e-05	0.000106	CcSEcCtD
Maraviroc—Body temperature increased—Losartan—hypertension	1.95e-05	0.000106	CcSEcCtD
Maraviroc—CCR5—Disease—NOS3—hypertension	1.95e-05	0.000182	CbGpPWpGaD
Maraviroc—CCR5—Disease—PIK3R1—hypertension	1.95e-05	0.000182	CbGpPWpGaD
Maraviroc—Nausea—Verapamil—hypertension	1.94e-05	0.000106	CcSEcCtD
Maraviroc—Asthenia—Captopril—hypertension	1.94e-05	0.000105	CcSEcCtD
Maraviroc—Diarrhoea—Trandolapril—hypertension	1.94e-05	0.000105	CcSEcCtD
Maraviroc—Vomiting—Valsartan—hypertension	1.94e-05	0.000105	CcSEcCtD
Maraviroc—Diarrhoea—Enalapril—hypertension	1.93e-05	0.000105	CcSEcCtD
Maraviroc—Hypersensitivity—Irbesartan—hypertension	1.93e-05	0.000105	CcSEcCtD
Maraviroc—Vomiting—Olmesartan—hypertension	1.93e-05	0.000105	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Ramipril—hypertension	1.92e-05	0.000105	CcSEcCtD
Maraviroc—Rash—Valsartan—hypertension	1.92e-05	0.000104	CcSEcCtD
Maraviroc—Dizziness—Clonidine—hypertension	1.92e-05	0.000104	CcSEcCtD
Maraviroc—Dermatitis—Valsartan—hypertension	1.92e-05	0.000104	CcSEcCtD
Maraviroc—Oedema—Lisinopril—hypertension	1.92e-05	0.000104	CcSEcCtD
Maraviroc—Pruritus—Captopril—hypertension	1.91e-05	0.000104	CcSEcCtD
Maraviroc—Hypersensitivity—Hydrochlorothiazide—hypertension	1.91e-05	0.000104	CcSEcCtD
Maraviroc—Rash—Olmesartan—hypertension	1.91e-05	0.000104	CcSEcCtD
Maraviroc—Insomnia—Ramipril—hypertension	1.91e-05	0.000104	CcSEcCtD
Maraviroc—Dermatitis—Olmesartan—hypertension	1.91e-05	0.000104	CcSEcCtD
Maraviroc—Headache—Valsartan—hypertension	1.91e-05	0.000104	CcSEcCtD
Maraviroc—Diarrhoea—Telmisartan—hypertension	1.9e-05	0.000103	CcSEcCtD
Maraviroc—Infection—Lisinopril—hypertension	1.9e-05	0.000103	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—ALDH2—hypertension	1.9e-05	0.000178	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PDGFB—hypertension	1.9e-05	0.000178	CbGpPWpGaD
Maraviroc—Headache—Olmesartan—hypertension	1.9e-05	0.000103	CcSEcCtD
Maraviroc—Paraesthesia—Ramipril—hypertension	1.9e-05	0.000103	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—FGFR1—hypertension	1.89e-05	0.000177	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypertension	1.89e-05	0.000177	CbGpPWpGaD
Maraviroc—Shock—Lisinopril—hypertension	1.88e-05	0.000102	CcSEcCtD
Maraviroc—Asthenia—Perindopril—hypertension	1.88e-05	0.000102	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Timolol—hypertension	1.88e-05	0.000102	CcSEcCtD
Maraviroc—Hypersensitivity—Furosemide—hypertension	1.88e-05	0.000102	CcSEcCtD
Maraviroc—Asthenia—Irbesartan—hypertension	1.88e-05	0.000102	CcSEcCtD
Maraviroc—Dizziness—Trandolapril—hypertension	1.87e-05	0.000102	CcSEcCtD
Maraviroc—Insomnia—Timolol—hypertension	1.87e-05	0.000101	CcSEcCtD
Maraviroc—Dizziness—Enalapril—hypertension	1.86e-05	0.000101	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—HIF1A—hypertension	1.86e-05	0.000174	CbGpPWpGaD
Maraviroc—Asthenia—Hydrochlorothiazide—hypertension	1.86e-05	0.000101	CcSEcCtD
Maraviroc—Hypersensitivity—Betaxolol—hypertension	1.86e-05	0.000101	CcSEcCtD
Maraviroc—Skin disorder—Lisinopril—hypertension	1.86e-05	0.000101	CcSEcCtD
Maraviroc—Pruritus—Perindopril—hypertension	1.86e-05	0.000101	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—AGT—hypertension	1.86e-05	0.000174	CbGpPWpGaD
Maraviroc—Paraesthesia—Timolol—hypertension	1.85e-05	0.000101	CcSEcCtD
Maraviroc—Pruritus—Irbesartan—hypertension	1.85e-05	0.000101	CcSEcCtD
Maraviroc—Diarrhoea—Captopril—hypertension	1.85e-05	0.000101	CcSEcCtD
Maraviroc—Vomiting—Clonidine—hypertension	1.85e-05	0.0001	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—CYP11A1—hypertension	1.84e-05	0.000172	CbGpPWpGaD
Maraviroc—Dizziness—Telmisartan—hypertension	1.84e-05	9.99e-05	CcSEcCtD
Maraviroc—Pruritus—Hydrochlorothiazide—hypertension	1.84e-05	9.98e-05	CcSEcCtD
Maraviroc—Decreased appetite—Ramipril—hypertension	1.84e-05	9.98e-05	CcSEcCtD
Maraviroc—Asthenia—Furosemide—hypertension	1.83e-05	9.95e-05	CcSEcCtD
Maraviroc—Rash—Clonidine—hypertension	1.83e-05	9.95e-05	CcSEcCtD
Maraviroc—Dermatitis—Clonidine—hypertension	1.83e-05	9.94e-05	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CALM1—hypertension	1.83e-05	0.000171	CbGpPWpGaD
Maraviroc—Anorexia—Lisinopril—hypertension	1.83e-05	9.92e-05	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Ramipril—hypertension	1.82e-05	9.91e-05	CcSEcCtD
Maraviroc—Fatigue—Ramipril—hypertension	1.82e-05	9.89e-05	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—APOE—hypertension	1.82e-05	0.00017	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LEP—hypertension	1.82e-05	0.00017	CbGpPWpGaD
Maraviroc—Headache—Clonidine—hypertension	1.82e-05	9.88e-05	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP11A1—hypertension	1.82e-05	0.00017	CbGpPWpGaD
Maraviroc—Hypersensitivity—Losartan—hypertension	1.81e-05	9.86e-05	CcSEcCtD
Maraviroc—Asthenia—Betaxolol—hypertension	1.81e-05	9.85e-05	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—GSTT1—hypertension	1.81e-05	0.000169	CbGpPWpGaD
Maraviroc—Nausea—Valsartan—hypertension	1.81e-05	9.83e-05	CcSEcCtD
Maraviroc—Pruritus—Furosemide—hypertension	1.81e-05	9.81e-05	CcSEcCtD
Maraviroc—Constipation—Ramipril—hypertension	1.81e-05	9.81e-05	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CAV1—hypertension	1.8e-05	0.000169	CbGpPWpGaD
Maraviroc—Nausea—Olmesartan—hypertension	1.8e-05	9.78e-05	CcSEcCtD
Maraviroc—Vomiting—Trandolapril—hypertension	1.8e-05	9.78e-05	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—APOA1—hypertension	1.8e-05	0.000168	CbGpPWpGaD
Maraviroc—CCR5—Disease—MTOR—hypertension	1.8e-05	0.000168	CbGpPWpGaD
Maraviroc—Diarrhoea—Perindopril—hypertension	1.8e-05	9.76e-05	CcSEcCtD
Maraviroc—Decreased appetite—Timolol—hypertension	1.79e-05	9.75e-05	CcSEcCtD
Maraviroc—Vomiting—Enalapril—hypertension	1.79e-05	9.74e-05	CcSEcCtD
Maraviroc—Diarrhoea—Irbesartan—hypertension	1.79e-05	9.73e-05	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—GCLC—hypertension	1.79e-05	0.000167	CbGpPWpGaD
Maraviroc—Dizziness—Captopril—hypertension	1.79e-05	9.72e-05	CcSEcCtD
Maraviroc—Pruritus—Betaxolol—hypertension	1.79e-05	9.72e-05	CcSEcCtD
Maraviroc—Rash—Trandolapril—hypertension	1.79e-05	9.7e-05	CcSEcCtD
Maraviroc—Dermatitis—Trandolapril—hypertension	1.78e-05	9.69e-05	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—KDR—hypertension	1.78e-05	0.000167	CbGpPWpGaD
Maraviroc—Gastrointestinal disorder—Timolol—hypertension	1.78e-05	9.69e-05	CcSEcCtD
Maraviroc—CCR5—Disease—PTGS2—hypertension	1.78e-05	0.000167	CbGpPWpGaD
Maraviroc—Fatigue—Timolol—hypertension	1.78e-05	9.67e-05	CcSEcCtD
Maraviroc—Rash—Enalapril—hypertension	1.78e-05	9.66e-05	CcSEcCtD
Maraviroc—Dermatitis—Enalapril—hypertension	1.78e-05	9.65e-05	CcSEcCtD
Maraviroc—Diarrhoea—Hydrochlorothiazide—hypertension	1.78e-05	9.65e-05	CcSEcCtD
Maraviroc—Headache—Trandolapril—hypertension	1.77e-05	9.64e-05	CcSEcCtD
Maraviroc—Vomiting—Telmisartan—hypertension	1.77e-05	9.61e-05	CcSEcCtD
Maraviroc—Asthenia—Losartan—hypertension	1.77e-05	9.6e-05	CcSEcCtD
Maraviroc—Headache—Enalapril—hypertension	1.77e-05	9.6e-05	CcSEcCtD
Maraviroc—Pain—Timolol—hypertension	1.77e-05	9.59e-05	CcSEcCtD
Maraviroc—Rash—Telmisartan—hypertension	1.75e-05	9.53e-05	CcSEcCtD
Maraviroc—Dermatitis—Telmisartan—hypertension	1.75e-05	9.52e-05	CcSEcCtD
Maraviroc—Diarrhoea—Furosemide—hypertension	1.75e-05	9.49e-05	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Lisinopril—hypertension	1.75e-05	9.48e-05	CcSEcCtD
Maraviroc—Pruritus—Losartan—hypertension	1.74e-05	9.47e-05	CcSEcCtD
Maraviroc—Headache—Telmisartan—hypertension	1.74e-05	9.47e-05	CcSEcCtD
Maraviroc—Dizziness—Perindopril—hypertension	1.74e-05	9.44e-05	CcSEcCtD
Maraviroc—Insomnia—Lisinopril—hypertension	1.73e-05	9.41e-05	CcSEcCtD
Maraviroc—Dizziness—Irbesartan—hypertension	1.73e-05	9.4e-05	CcSEcCtD
Maraviroc—Diarrhoea—Betaxolol—hypertension	1.73e-05	9.4e-05	CcSEcCtD
Maraviroc—Gastrointestinal pain—Ramipril—hypertension	1.73e-05	9.38e-05	CcSEcCtD
Maraviroc—Nausea—Clonidine—hypertension	1.72e-05	9.37e-05	CcSEcCtD
Maraviroc—Paraesthesia—Lisinopril—hypertension	1.72e-05	9.34e-05	CcSEcCtD
Maraviroc—Vomiting—Captopril—hypertension	1.72e-05	9.34e-05	CcSEcCtD
Maraviroc—Dizziness—Hydrochlorothiazide—hypertension	1.72e-05	9.33e-05	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—F2—hypertension	1.72e-05	0.000161	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PRKCB—hypertension	1.72e-05	0.000161	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FN1—hypertension	1.72e-05	0.000161	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP17A1—hypertension	1.71e-05	0.00016	CbGpPWpGaD
Maraviroc—Rash—Captopril—hypertension	1.71e-05	9.27e-05	CcSEcCtD
Maraviroc—Dermatitis—Captopril—hypertension	1.7e-05	9.26e-05	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—PTGS1—hypertension	1.7e-05	0.000159	CbGpPWpGaD
Maraviroc—Headache—Captopril—hypertension	1.69e-05	9.21e-05	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP17A1—hypertension	1.69e-05	0.000158	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Timolol—hypertension	1.69e-05	9.17e-05	CcSEcCtD
Maraviroc—Dizziness—Furosemide—hypertension	1.69e-05	9.17e-05	CcSEcCtD
Maraviroc—Diarrhoea—Losartan—hypertension	1.69e-05	9.16e-05	CcSEcCtD
Maraviroc—Nausea—Trandolapril—hypertension	1.68e-05	9.14e-05	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—NOTCH1—hypertension	1.68e-05	0.000157	CbGpPWpGaD
Maraviroc—Nausea—Enalapril—hypertension	1.68e-05	9.1e-05	CcSEcCtD
Maraviroc—Dizziness—Betaxolol—hypertension	1.67e-05	9.08e-05	CcSEcCtD
Maraviroc—Vomiting—Perindopril—hypertension	1.67e-05	9.07e-05	CcSEcCtD
Maraviroc—Abdominal pain—Ramipril—hypertension	1.67e-05	9.07e-05	CcSEcCtD
Maraviroc—Body temperature increased—Ramipril—hypertension	1.67e-05	9.07e-05	CcSEcCtD
Maraviroc—Decreased appetite—Lisinopril—hypertension	1.67e-05	9.05e-05	CcSEcCtD
Maraviroc—Vomiting—Irbesartan—hypertension	1.66e-05	9.04e-05	CcSEcCtD
Maraviroc—Rash—Perindopril—hypertension	1.66e-05	9e-05	CcSEcCtD
Maraviroc—Dermatitis—Perindopril—hypertension	1.65e-05	8.99e-05	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Lisinopril—hypertension	1.65e-05	8.98e-05	CcSEcCtD
Maraviroc—Nausea—Telmisartan—hypertension	1.65e-05	8.98e-05	CcSEcCtD
Maraviroc—Fatigue—Lisinopril—hypertension	1.65e-05	8.97e-05	CcSEcCtD
Maraviroc—Vomiting—Hydrochlorothiazide—hypertension	1.65e-05	8.97e-05	CcSEcCtD
Maraviroc—Rash—Irbesartan—hypertension	1.65e-05	8.97e-05	CcSEcCtD
Maraviroc—Dermatitis—Irbesartan—hypertension	1.65e-05	8.96e-05	CcSEcCtD
Maraviroc—Headache—Perindopril—hypertension	1.65e-05	8.94e-05	CcSEcCtD
Maraviroc—Headache—Irbesartan—hypertension	1.64e-05	8.91e-05	CcSEcCtD
Maraviroc—Constipation—Lisinopril—hypertension	1.64e-05	8.9e-05	CcSEcCtD
Maraviroc—Pain—Lisinopril—hypertension	1.64e-05	8.9e-05	CcSEcCtD
Maraviroc—Rash—Hydrochlorothiazide—hypertension	1.64e-05	8.89e-05	CcSEcCtD
Maraviroc—Dermatitis—Hydrochlorothiazide—hypertension	1.64e-05	8.88e-05	CcSEcCtD
Maraviroc—Body temperature increased—Timolol—hypertension	1.63e-05	8.87e-05	CcSEcCtD
Maraviroc—Abdominal pain—Timolol—hypertension	1.63e-05	8.87e-05	CcSEcCtD
Maraviroc—Dizziness—Losartan—hypertension	1.63e-05	8.85e-05	CcSEcCtD
Maraviroc—Headache—Hydrochlorothiazide—hypertension	1.63e-05	8.84e-05	CcSEcCtD
Maraviroc—Vomiting—Furosemide—hypertension	1.62e-05	8.82e-05	CcSEcCtD
Maraviroc—Rash—Furosemide—hypertension	1.61e-05	8.75e-05	CcSEcCtD
Maraviroc—Dermatitis—Furosemide—hypertension	1.61e-05	8.74e-05	CcSEcCtD
Maraviroc—Vomiting—Betaxolol—hypertension	1.61e-05	8.73e-05	CcSEcCtD
Maraviroc—Nausea—Captopril—hypertension	1.61e-05	8.73e-05	CcSEcCtD
Maraviroc—Headache—Furosemide—hypertension	1.6e-05	8.69e-05	CcSEcCtD
Maraviroc—Rash—Betaxolol—hypertension	1.59e-05	8.66e-05	CcSEcCtD
Maraviroc—Dermatitis—Betaxolol—hypertension	1.59e-05	8.65e-05	CcSEcCtD
Maraviroc—Headache—Betaxolol—hypertension	1.58e-05	8.6e-05	CcSEcCtD
Maraviroc—Gastrointestinal pain—Lisinopril—hypertension	1.57e-05	8.51e-05	CcSEcCtD
Maraviroc—Vomiting—Losartan—hypertension	1.57e-05	8.51e-05	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—POMC—hypertension	1.56e-05	0.000146	CbGpPWpGaD
Maraviroc—Nausea—Perindopril—hypertension	1.56e-05	8.47e-05	CcSEcCtD
Maraviroc—CCR5—Disease—CDKN1A—hypertension	1.56e-05	0.000146	CbGpPWpGaD
Maraviroc—Hypersensitivity—Ramipril—hypertension	1.56e-05	8.45e-05	CcSEcCtD
Maraviroc—Nausea—Irbesartan—hypertension	1.55e-05	8.45e-05	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—INS—hypertension	1.55e-05	0.000146	CbGpPWpGaD
Maraviroc—Rash—Losartan—hypertension	1.55e-05	8.44e-05	CcSEcCtD
Maraviroc—CCR5—Disease—PTEN—hypertension	1.55e-05	0.000145	CbGpPWpGaD
Maraviroc—Dermatitis—Losartan—hypertension	1.55e-05	8.43e-05	CcSEcCtD
Maraviroc—Headache—Losartan—hypertension	1.54e-05	8.38e-05	CcSEcCtD
Maraviroc—Nausea—Hydrochlorothiazide—hypertension	1.54e-05	8.38e-05	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypertension	1.53e-05	0.000144	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL2—hypertension	1.53e-05	0.000143	CbGpPWpGaD
Maraviroc—Hypersensitivity—Timolol—hypertension	1.52e-05	8.27e-05	CcSEcCtD
Maraviroc—Nausea—Furosemide—hypertension	1.52e-05	8.24e-05	CcSEcCtD
Maraviroc—Asthenia—Ramipril—hypertension	1.52e-05	8.23e-05	CcSEcCtD
Maraviroc—Abdominal pain—Lisinopril—hypertension	1.51e-05	8.23e-05	CcSEcCtD
Maraviroc—Body temperature increased—Lisinopril—hypertension	1.51e-05	8.23e-05	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IGF1—hypertension	1.5e-05	0.000141	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AKT2—hypertension	1.5e-05	0.000141	CbGpPWpGaD
Maraviroc—Nausea—Betaxolol—hypertension	1.5e-05	8.16e-05	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—EGFR—hypertension	1.5e-05	0.00014	CbGpPWpGaD
Maraviroc—Pruritus—Ramipril—hypertension	1.49e-05	8.12e-05	CcSEcCtD
Maraviroc—Asthenia—Timolol—hypertension	1.48e-05	8.05e-05	CcSEcCtD
Maraviroc—CCR5—Disease—EP300—hypertension	1.48e-05	0.000139	CbGpPWpGaD
Maraviroc—Nausea—Losartan—hypertension	1.46e-05	7.95e-05	CcSEcCtD
Maraviroc—Pruritus—Timolol—hypertension	1.46e-05	7.94e-05	CcSEcCtD
Maraviroc—Diarrhoea—Ramipril—hypertension	1.45e-05	7.85e-05	CcSEcCtD
Maraviroc—CCR5—Disease—SRC—hypertension	1.44e-05	0.000135	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SERPINE1—hypertension	1.43e-05	0.000134	CbGpPWpGaD
Maraviroc—Diarrhoea—Timolol—hypertension	1.41e-05	7.68e-05	CcSEcCtD
Maraviroc—Hypersensitivity—Lisinopril—hypertension	1.41e-05	7.67e-05	CcSEcCtD
Maraviroc—Dizziness—Ramipril—hypertension	1.4e-05	7.59e-05	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—FGF2—hypertension	1.38e-05	0.000129	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RHOA—hypertension	1.38e-05	0.000129	CbGpPWpGaD
Maraviroc—Asthenia—Lisinopril—hypertension	1.37e-05	7.47e-05	CcSEcCtD
Maraviroc—Dizziness—Timolol—hypertension	1.37e-05	7.42e-05	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PIK3R1—hypertension	1.36e-05	0.000128	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NOS3—hypertension	1.36e-05	0.000128	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP19A1—hypertension	1.36e-05	0.000127	CbGpPWpGaD
Maraviroc—Pruritus—Lisinopril—hypertension	1.36e-05	7.36e-05	CcSEcCtD
Maraviroc—Vomiting—Ramipril—hypertension	1.34e-05	7.3e-05	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP19A1—hypertension	1.34e-05	0.000125	CbGpPWpGaD
Maraviroc—Rash—Ramipril—hypertension	1.33e-05	7.24e-05	CcSEcCtD
Maraviroc—Dermatitis—Ramipril—hypertension	1.33e-05	7.23e-05	CcSEcCtD
Maraviroc—Headache—Ramipril—hypertension	1.32e-05	7.19e-05	CcSEcCtD
Maraviroc—Vomiting—Timolol—hypertension	1.31e-05	7.13e-05	CcSEcCtD
Maraviroc—Diarrhoea—Lisinopril—hypertension	1.31e-05	7.12e-05	CcSEcCtD
Maraviroc—Rash—Timolol—hypertension	1.3e-05	7.07e-05	CcSEcCtD
Maraviroc—Dermatitis—Timolol—hypertension	1.3e-05	7.07e-05	CcSEcCtD
Maraviroc—Headache—Timolol—hypertension	1.29e-05	7.03e-05	CcSEcCtD
Maraviroc—CCR5—Disease—MYC—hypertension	1.29e-05	0.000121	CbGpPWpGaD
Maraviroc—CCR5—Disease—TGFB1—hypertension	1.29e-05	0.00012	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RELA—hypertension	1.28e-05	0.00012	CbGpPWpGaD
Maraviroc—Dizziness—Lisinopril—hypertension	1.27e-05	6.88e-05	CcSEcCtD
Maraviroc—CCR5—Disease—EGFR—hypertension	1.26e-05	0.000118	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—COMT—hypertension	1.26e-05	0.000118	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MTOR—hypertension	1.26e-05	0.000118	CbGpPWpGaD
Maraviroc—Nausea—Ramipril—hypertension	1.25e-05	6.82e-05	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—COMT—hypertension	1.24e-05	0.000116	CbGpPWpGaD
Maraviroc—Nausea—Timolol—hypertension	1.23e-05	6.66e-05	CcSEcCtD
Maraviroc—Vomiting—Lisinopril—hypertension	1.22e-05	6.62e-05	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CXCL8—hypertension	1.21e-05	0.000113	CbGpPWpGaD
Maraviroc—Rash—Lisinopril—hypertension	1.21e-05	6.56e-05	CcSEcCtD
Maraviroc—Dermatitis—Lisinopril—hypertension	1.21e-05	6.56e-05	CcSEcCtD
Maraviroc—Headache—Lisinopril—hypertension	1.2e-05	6.52e-05	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—AKT1—hypertension	1.17e-05	0.000109	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GSTM1—hypertension	1.15e-05	0.000108	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL6—hypertension	1.15e-05	0.000108	CbGpPWpGaD
Maraviroc—Nausea—Lisinopril—hypertension	1.14e-05	6.18e-05	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—GSTM1—hypertension	1.14e-05	0.000106	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MMP9—hypertension	1.09e-05	0.000102	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP1A1—hypertension	1.09e-05	0.000102	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CDKN1A—hypertension	1.09e-05	0.000102	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PTEN—hypertension	1.09e-05	0.000102	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—FAH—hypertension	1.08e-05	0.000101	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP1A1—hypertension	1.08e-05	0.000101	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MAPK8—hypertension	1.06e-05	9.96e-05	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—AKT1—hypertension	1.06e-05	9.93e-05	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—EP300—hypertension	1.04e-05	9.71e-05	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SRC—hypertension	1.01e-05	9.44e-05	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—VEGFA—hypertension	9.82e-06	9.19e-05	CbGpPWpGaD
Maraviroc—CCR5—Disease—IL6—hypertension	9.7e-06	9.08e-05	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MYC—hypertension	9.04e-06	8.46e-05	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TGFB1—hypertension	9.01e-06	8.44e-05	CbGpPWpGaD
Maraviroc—CCR5—Disease—AKT1—hypertension	8.95e-06	8.38e-05	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—EGFR—hypertension	8.84e-06	8.27e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HAS3—hypertension	8.17e-06	7.65e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HAS2—hypertension	8.17e-06	7.65e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PNMT—hypertension	8.17e-06	7.65e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—QDPR—hypertension	8.17e-06	7.65e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HYAL2—hypertension	8.17e-06	7.65e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HAS1—hypertension	8.17e-06	7.65e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—POMC—hypertension	8.15e-06	7.63e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTA5—hypertension	7.69e-06	7.19e-05	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TP53—hypertension	7.42e-06	6.95e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CDO1—hypertension	7.29e-06	6.82e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CPS1—hypertension	7.29e-06	6.82e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HYAL1—hypertension	7.29e-06	6.82e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MDH1—hypertension	7.29e-06	6.82e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTT2—hypertension	7.29e-06	6.82e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP4F12—hypertension	6.95e-06	6.51e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GCH1—hypertension	6.95e-06	6.51e-05	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6—hypertension	6.79e-06	6.36e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLCD1—hypertension	6.66e-06	6.24e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AHCY—hypertension	6.41e-06	6e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP11B1—hypertension	6.41e-06	6e-05	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AKT1—hypertension	6.27e-06	5.87e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DBH—hypertension	6.19e-06	5.8e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GBA—hypertension	6.19e-06	5.8e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—EPHX2—hypertension	6.19e-06	5.8e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTM5—hypertension	6.19e-06	5.8e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALOX12—hypertension	6.19e-06	5.8e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP2J2—hypertension	6e-06	5.62e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GLS2—hypertension	5.82e-06	5.45e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ARG1—hypertension	5.82e-06	5.45e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—COX5B—hypertension	5.82e-06	5.45e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DECR1—hypertension	5.82e-06	5.45e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALAD—hypertension	5.52e-06	5.17e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLCE1—hypertension	5.27e-06	4.93e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—STS—hypertension	5.27e-06	4.93e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALDH7A1—hypertension	5.27e-06	4.93e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CBS—hypertension	5.05e-06	4.73e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ARG2—hypertension	5.05e-06	4.73e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP4A11—hypertension	5.05e-06	4.73e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—XDH—hypertension	4.95e-06	4.64e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTGIS—hypertension	4.86e-06	4.55e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP3A5—hypertension	4.86e-06	4.55e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SLC5A2—hypertension	4.86e-06	4.55e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HSD11B1—hypertension	4.69e-06	4.39e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—TPH1—hypertension	4.69e-06	4.39e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—UCP2—hypertension	4.69e-06	4.39e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—UCP3—hypertension	4.69e-06	4.39e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ABCC1—hypertension	4.69e-06	4.39e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SLC2A3—hypertension	4.55e-06	4.26e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALAS1—hypertension	4.55e-06	4.26e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP11B2—hypertension	4.55e-06	4.26e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HSD3B1—hypertension	4.48e-06	4.19e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADA—hypertension	4.48e-06	4.19e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—FADS1—hypertension	4.41e-06	4.13e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AQP1—hypertension	4.41e-06	4.13e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—TBXAS1—hypertension	4.29e-06	4.02e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CA9—hypertension	4.29e-06	4.02e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALOX5AP—hypertension	4.18e-06	3.92e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALOX15—hypertension	4.18e-06	3.92e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LHB—hypertension	4.08e-06	3.82e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HADHA—hypertension	4.08e-06	3.82e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LPA—hypertension	3.99e-06	3.74e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—KCNJ11—hypertension	3.99e-06	3.74e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HSD3B2—hypertension	3.99e-06	3.74e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP2C18—hypertension	3.83e-06	3.58e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LRP2—hypertension	3.83e-06	3.58e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HSPG2—hypertension	3.68e-06	3.45e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GLP1R—hypertension	3.56e-06	3.33e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALOX5—hypertension	3.56e-06	3.33e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALDH2—hypertension	3.25e-06	3.05e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HBA1—hypertension	3.17e-06	2.97e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP11A1—hypertension	3.15e-06	2.95e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SLC9A1—hypertension	3.1e-06	2.9e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTT1—hypertension	3.1e-06	2.9e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GCLC—hypertension	3.06e-06	2.86e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CETP—hypertension	3.06e-06	2.86e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP17A1—hypertension	2.93e-06	2.74e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTGS1—hypertension	2.9e-06	2.71e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ENO1—hypertension	2.9e-06	2.71e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CTGF—hypertension	2.79e-06	2.61e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HMGCR—hypertension	2.77e-06	2.59e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GOT2—hypertension	2.77e-06	2.59e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADRA2A—hypertension	2.71e-06	2.53e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—TH—hypertension	2.54e-06	2.37e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CALM2—hypertension	2.53e-06	2.36e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SLC2A4—hypertension	2.47e-06	2.31e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GCG—hypertension	2.47e-06	2.31e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GOT1—hypertension	2.39e-06	2.24e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP19A1—hypertension	2.32e-06	2.17e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—STK11—hypertension	2.32e-06	2.17e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—COMT—hypertension	2.16e-06	2.02e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARGC1A—hypertension	2.13e-06	1.99e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GNB3—hypertension	2.13e-06	1.99e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HMOX1—hypertension	2.12e-06	1.98e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CAT—hypertension	2.09e-06	1.95e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GNAS—hypertension	2.07e-06	1.94e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOB—hypertension	2.03e-06	1.9e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTM1—hypertension	1.97e-06	1.85e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LPL—hypertension	1.94e-06	1.81e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADCY5—hypertension	1.89e-06	1.77e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GPX1—hypertension	1.89e-06	1.77e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PRKCA—hypertension	1.87e-06	1.75e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP1A1—hypertension	1.87e-06	1.75e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CD36—hypertension	1.84e-06	1.72e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MTHFR—hypertension	1.74e-06	1.63e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARA—hypertension	1.71e-06	1.6e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AGT—hypertension	1.66e-06	1.55e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CALM1—hypertension	1.63e-06	1.52e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOE—hypertension	1.62e-06	1.52e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CAV1—hypertension	1.61e-06	1.5e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOA1—hypertension	1.6e-06	1.5e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARG—hypertension	1.41e-06	1.32e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—POMC—hypertension	1.39e-06	1.3e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—INS—hypertension	1.39e-06	1.3e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALB—hypertension	1.27e-06	1.19e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NOS3—hypertension	1.22e-06	1.14e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PIK3R1—hypertension	1.22e-06	1.14e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTGS2—hypertension	1.11e-06	1.04e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTEN—hypertension	9.69e-07	9.07e-06	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—EP300—hypertension	9.24e-07	8.65e-06	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AKT1—hypertension	5.59e-07	5.23e-06	CbGpPWpGaD
